Anticipate outbreaks.
Mitigate risk. Build resilience.

BlueDot empowers responses to infectious disease risk using human and artificial intelligence.
AS SEEN IN
AS USED BY
Ahead of the curve throughout the pandemic
BlueDot was among the first in the world to identify the emerging risk from COVID-19 in Hubei province and notify our clients via our Insights platform.
BlueDot published the first scientific paper on COVID-19, accurately predicting eight of the first ten cities to import the novel coronavirus.
BlueDot's COVID Data Suite delivers bespoke, near-real-time intelligence to governments, hospitals and airlines, revealing COVID-19’s movements.
BlueDot's regular Focus Reports identified India and Brazil as future epicentres months before case counts in those regions began to climb.
A track record of accurately assessing outbreak risk
BlueDot founded
2013
Our mission: To create a global early warning system for infectious disease.
Ebola
2014
Accurately identified importation risks from outbreak in West Africa.
Zika
2016
Predicted spread of Zika virus to Florida six months before official reports.
COVID-19
2019
Identified undiagnosed pneumonia in Wuhan on December 31.
Timely. Tailored. Trustworthy.